BioXcel Therapeutics (BTAIQ) Return on Equity [ROE] (2018 - 2023)
BioXcel Therapeutics' Return on Equity [ROE] was -1770.83% in FY2023, down 1660.03 percentage points from -110.80% in FY2022.
Powered by 
Analysis
BioXcel Therapeutics (BTAIQ) Return on Equity [ROE] (2018 - 2023) Analysis & Trends
From FY2018 onward, BioXcel Therapeutics has reported Return on Equity [ROE] for 6 years.
- Return on Equity [ROE] shows a five-year change of -1665.51 percentage points (FY2018 to FY2023).
- The FY2023 figure marks the lowest annual Return on Equity [ROE] in data going back to FY2018.
- Per Business Quant data, Return on Equity [ROE] in earlier years was -110.80% in FY2022 (-60.87 pp), -49.93% in FY2021 (+20.43 pp), -70.35% in FY2020 (+31.86 pp) and -102.22% in FY2019 (+3.10 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 4.97% |
| 10 | BioXcel Therapeutics | 1.57 Mn | 1.57 Mn | 160,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -688.98% |
| Mar 31, 2023 | -287.28% |
| Dec 31, 2022 | -162.29% |
| Sep 30, 2022 | -94.17% |
| Jun 30, 2022 | -68.15% |
| Mar 31, 2022 | -53.90% |
| Dec 31, 2021 | -45.77% |
| Sep 30, 2021 | -39.73% |
| Jun 30, 2021 | -43.97% |
| Mar 31, 2021 | -47.60% |
| Dec 31, 2020 | -38.43% |
| Sep 30, 2020 | -50.65% |
| Jun 30, 2020 | -85.52% |
| Mar 31, 2020 | -82.60% |
| Dec 31, 2019 | -109.57% |
| Sep 30, 2019 | -109.17% |
| Jun 30, 2019 | -99.04% |
| Mar 31, 2019 | -64.82% |
| Dec 31, 2018 | -47.13% |
| Sep 30, 2018 | -31.73% |
API Access
BioXcel Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BTAIQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "BTAIQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();